Rheumatoid Arthritis

An autoimmune disease called rheumatoid arthritis (RA) damages joints and causes inflammation. Commonly used therapies include injections of Etanercept 50 mg and tablets of Plaquenil Hydroxychloroquine. Etanercept reduces joint swelling and pain by targeting tumour necrosis factor (TNF), while hydroxychloroquine suppresses the immune system to assist reduce inflammation. These drugs are made using sophisticated pharmaceutical synthesis methods and come in a variety of formats, such as tablets and injections. By managing symptoms and halting additional joint degradation, they greatly enhance RA sufferers' mobility and quality of life. They are mostly utilised in the medical field. Long-term advantages for controlling this chronic illness are guaranteed when administered properly.